Cambridge Investment Research Advisors, Inc. Renovo Rx, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
BUY
$2.51 - $5.25 $1,255 - $2,625
500 Added 3.47%
14,900 $52,000
Q4 2021

Feb 03, 2022
SELL
$4.72 - $8.5 $124,844 - $224,825
-26,450 Reduced 64.75%
14,400 $69,000
Q3 2021

Nov 02, 2021
BUY
$6.04 - $16.02 $246,734 - $654,417
40,850 New
40,850 $246,000

Others Institutions Holding RNXT

# of Institutions
18
Shares Held
1.87M
Call Options Held
0
Put Options Held
0
View Full List

About RenovoRx, Inc.

RNXT Quotes by TradingView
  • Ticker RNXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,066,860
  • Market Cap $9.25M
  • Description
  • RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...
More about RNXT
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email